Foresight Group, a leading regional private equity and infrastructure investment manager, has announced a £3 million investment into MyWay Digital Health Ltd, a digital healthcare solutions provider dedicated to reducing the burden of chronic disease, with a particular emphasis on diabetes.
Spun out of the University of Dundee in 2017, MyWay employs 30 staff across Dundee, Edinburgh, and London. Its mission is to improve the lives of individuals living with long-term conditions through cost-effective, data-driven, personalised health technology. Its suite of products spans diabetes prevention, cardiovascular health, hypertension, and weight management.
The company’s flagship platform, MyWay Diabetes, is a clinically validated digital self-management tool that integrates with NHS systems to provide personalised education, data visualisation, and actionable insights for patients and clinicians. The platform has been adopted both across multiple NHS regions and internationally, demonstrating measurable improvements in patient engagement and health outcomes.
Foresight’s investment will enable MyWay to accelerate the development of new AI-enabled products, including predictive analytics and personalised care pathways, while expanding its commercial footprint to meet growing global demand for scalable digital health solutions.
My Way Digital health has launched free Open Online Courses (OOCs). On 26-27 November there is one called ‘understanding Type 1 diabetes’. To find out more, CLICK HERE.
